Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.61 | N/A | -9.62% |
management commentary, guidance changes, and full analysis available with Pro.
| -9.62% |
Tone: Defensive
Overall, management expressed concerns about market conditions impacting performance. They highlighted their commitment to improving operational efficiency.
Management acknowledged the challenges faced in the quarter.
They emphasized a focus on cost control moving forward.
The earnings report indicates that Prestige Consumer HE fell short of expectations on EPS, which contributed to a significant drop in stock price. Investors reacted negatively, likely due to concerns over the company's performance amid challenging market conditions. Without any guidance updates, uncertainty remains about the company's future direction.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ROPER TECHNOLOGIES I
Oct 30, 2017